Range of published estimates of venous thromboembolism incidence in young women

Contraception

Volumn 75, Issue 5, 2007, Pages 328-336

  Heinemann, Lothar A J ^a   Dinger, Jürgen C ^a  

^a Health Research Berlin   (Germany)

Author keywords

Deep venous thrombosis; Incidence rates; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ALGORITHM; COMMUNITY CARE; CONTROLLED STUDY; DATA BASE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INCIDENCE; MEDICAL LITERATURE; MEDLINE; PUBLICATION; REVIEW; VENOUS THROMBOEMBOLISM;

ADULT; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INCIDENCE; THROMBOEMBOLISM;

EID: 34047257862     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.12.018     Document Type: Review

References (42)

1. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346 (1995) 1582-1588
2. Spitzer W.O., Lewis M.A., Heinemann L.A., Thorogood M., and MacRae K.D. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 312 (1996) 83-88
3. Heinemann L.A.J., Lewis M.A., Assmann A., and Thiel C. Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use. Contraception 65 (2002) 207-214
4. Scurr J.H., Machin S.J., Bailey-King S., Mackie I.J., McDonald S., and Smith P.D. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 357 (2001) 1485-1489
5. Belcaro G., Geroulakos G., Nicolaides A.N., Myers K.A., and Winford M. Venous thromboembolism from air travel: the LONFLIT study. Angiology 52 (2001) 369-374
6. Schwarz T., Siegert G., Oettler W., et al. Venous thrombosis following long-haul flights. Arch Intern Med 163 (2003) 2759-2764
7. European Agency for the Evaluation of Medicinal Products. Combined oral contraceptives and venous thromboembolism. The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products (CPMP); public assessment report. London, 28 September 2001. [online] Available from. http://www.emea.eu.int/pdfs/human/regaffair/0220101en.pdf [Accessed Oct. 30, 2006]
8. Fowkes F.J., Price J.F., and Fowkes F.G. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25 (2003) 1-5
9. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 151 (1991) 933-938
10. Kniffin W.D., Baron J.A., Barrett J., Birkmeyer J.D., and Anderson F.A. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Int Med 154 (1994) 861-866
11. Nordström M., Lindblad B., Bergqvist D., and Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232 (1992) 155-160
12. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Trends in the incidence of deep venous thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158 (1998) 585-593
13. Nylander G., and Olivecrona H. The phlebographic pattern of acute leg thrombosis within a defined urban population. Acta Chir Scand 142 (1976) 505-511
14. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts. Acta Chir Scand 146 (1980) 267-269
15. Juul K., Tybjaerg-Hansen A., Schnohr P., and Nordestgaard B.G. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 140 (2004) 330-3377
16. Oger E., and for the EPI-GETBO Study Group. Incidence of venous thromboembolism: a community-based study in western France. Thromb Haemost 83 (2000) 657-660
17. Gjores J.E. The incidence of venous thrombosis and its sequelae in certain districts of Sweden. Acta Chir Scand Suppl 206 Suppl (1956) 1-88
18. Coon W.W., Willis P.W., and Keller J.B. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 48 (1973) 839-846
19. Royal College of General Practitioners. Oral contraceptives and health: an interim report from the oral contraception study of the Royal College of General Practitioners (1974), Pitman Medical, London
20. Kay C.R. Oral contraceptives and venous thrombosis (letter). Lancet 1 (1975) 1381
21. Royal College of General Practitioners. Oral contraception study. Oral contraceptives, venous thrombosis, and varicose veins. J R Coll Gen Pract 28 (1978) 393-399
22. Vessey M., Doll R., Peto R., Johnson B., and Wiggins P. A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 8 (1976) 373-427
23. Vessey M.P., and Mann J.I. Female sex hormones and thrombosis. Br Med Bull 34 (1978) 157-162
24. Vessey M., Mant D., Smith A., and Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. BMJ 292 (1986) 526
25. Heinemann L.A.J., DoMinh T., Assmann A., et al. VTE risk assessment - a prognostic model: BATER cohort study of young women. Thrombosis J 3 (2005) 5. http://www.thrombosisjournal.com/content/3/1/5 (18 April 2005) online: http://www.thrombosisjournal.com/content/3/1/5 [Accessed Nov. 2, 2006].
26. Dinger J.C., Heinemann L.A.J., and Kuehl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives (EURAS-OC) based on 142,475 women-years of observation. Contraception 75 (2007) 344-354
27. Ludwig H. Anovulatory agents and venous disease. Ergebnisse Angiol Phlebolo 4 (1970) 81-102
28. Fuertes de la Haba A., Curet J.O., Pelegrina I., and Bangdiwala I. Thrombophlebitis among oral and nonoral contraceptive users. Obstet Gynecol 38 (1971) 259-263
29. Ridker P.M., Glynn R.J., Miletich J.P., Goldhaber S.Z., Stampfer M.J., and Hennekens C.H. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126 (1997) 528-531
30. Middeldorp S., Meinardi J.R., Koopman M.M.W., et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 135 (2001) 322-327
31. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 288 (2002) 321-333
32. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 291 (2004) 1701-1712
33. Porter J.B., Hunter J.R., Danielson D.A., Jick H., and Stergachis A. Oral contraceptives and nonfatal vascular disease - recent experience. Obstet Gynecol 59 (1982) 299-302
34. Gillum R.F. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 114 (1987) 1262-1264
35. Farmer R.D.T., and Preston T.D. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J Obstet Gynaecol 15 (1995) 195-200
36. White R.H., Zhou H., and Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128 (1998) 737-740
37. Jick H., Jick S.S., Gurewich V., Myers M.W., and Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346 (1995) 1589-1593
38. Gerstman B.B., Piper J.M., Freiman J.P., et al. Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism. Int J Epidemiol 19 (1990) 931-936
39. Farmer R.D., Lawrenson R.A., Thompson C.R., Kennedy J.G., and Hambleton I.R. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 349 (1997) 83-88
40. Farmer R.D., Lawrenson R.A., Todd J.C., Williams T.J., and MacRae K. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK MediPlus Database. Hum Reprod 5 (1999) 688-706
41. Jick H., Kaye J.A., Vasilakis-Scaramozza C., and Jick S.S. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 321 (2000) 1190-1195
42. Drill V.A. Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies. JAMA 219 (1972) 583-592